Structure modeling and antidiabetic activity of a seed protein of Momordica charantia in non-obese diabetic (NOD) mice

被引:10
作者
Chhabra, Gagan [1 ]
Dixit, Aparna [1 ]
机构
[1] Jawaharlal Nehru Univ, Sch Biotechnol, Gene Regulat Lab, New Delhi 110067, India
关键词
Momordica charantia; homology modeling; structure validation;
D O I
10.6026/97320630009766
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Momordica charantia is a well known medicinal plant used in the traditional medicinal system for the treatment of various diseases including diabetes mellitus. Recently, a novel protein termed as ADMc1 from the seed extract of M. charantia has been identified and isolated showing significant antihyperglycemic activity in type 1 diabetic rats in which diabetes was induced. However, the structure of this protein has not yet been analyzed. Homology modeling approach was used to generate a high quality protein 3D structure for the amino acid sequence of the ADMc1 protein in this study. The comparative assessment of secondary structures revealed ADMc1 as an all-alpha helix protein with random coils. Tertiary structure predicted on the template structure of Napin of B. Napus (PDB ID: 1SM7) with which the ADMc1 showed significant sequence similarity, was validated using protein structure validation tools like PROCHECK, WHAT_CHECK, VERIFY3D and ProSA. Arrangement of disulfide bridges formed by cysteine residues were predicted by the Dianna 1.1 server. The presence of multiple disulfide bond confers the stable nature of the ADMc1 protein. Further, the biological activity of the ADMc1 was assessed in non-obese diabetic (NOD) mice which are spontaneous model of type 1 diabetes. Significant reduction in the blood glucose levels of NOD mice was observed up to 8 h post administration of the rADMc1 protein. Overall, the structural characterizations with antihyperglycemic activity of this seed protein of Momordica charantia demonstrate its potential as an antidiabetic agent.
引用
收藏
页码:766 / 770
页数:5
相关论文
共 21 条
[1]   STUDIES ON HYPOGLYCEMIC EFFECTS OF FRUIT PULP, SEED, AND WHOLE-PLANT OF MOMORDICA-CHARANTIA ON NORMAL AND DIABETIC MODEL RATS [J].
ALI, L ;
KHAN, AKA ;
MAMUN, MIR ;
MOSIHUZZAMAN, M ;
NAHAR, N ;
NUREALAM, M ;
ROKEYA, B .
PLANTA MEDICA, 1993, 59 (05) :408-412
[2]   Moving towards efficient therapies in type 1 diabetes: To combine or not to combine? [J].
Bresson, D. ;
von Herrath, M. .
AUTOIMMUNITY REVIEWS, 2007, 6 (05) :315-322
[3]  
Brusotti G, 2013, J PHARM BIOMED ANAL, V13
[4]   Comprehensive Evaluation of Anti-hyperglycemic Activity of Fractionated Momordica charantia Seed Extract in Alloxan-Induced Diabetic Rats [J].
Choudhary, Shailesh Kumar ;
Chhabra, Gagan ;
Sharma, Dipali ;
Vashishta, Aruna ;
Ohri, Sujata ;
Dixit, Aparna .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
[5]   The Jpred 3 secondary structure prediction server [J].
Cole, Christian ;
Barber, Jonathan D. ;
Barton, Geoffrey J. .
NUCLEIC ACIDS RESEARCH, 2008, 36 :W197-W201
[6]   HYPOGLYCEMIC EFFECT OF MOMORDICA-CHARANTIA EXTRACTS [J].
DAY, C ;
CARTWRIGHT, T ;
PROVOST, J ;
BAILEY, CJ .
PLANTA MEDICA, 1990, 56 (05) :426-429
[7]  
Dixit A, European patent, Patent No. 2132222
[8]   VERIFY3D: Assessment of protein models with three-dimensional profiles [J].
Eisenberg, D ;
Luthy, R ;
Bowie, JU .
MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 :396-404
[9]   An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract [J].
Fernandes N.P.C. ;
Lagishetty C.V. ;
Panda V.S. ;
Naik S.R. .
BMC Complementary and Alternative Medicine, 7 (1)
[10]   Pharmacological actions and potential uses of Momordica charantia:: a review [J].
Grover, JK ;
Yadav, SP .
JOURNAL OF ETHNOPHARMACOLOGY, 2004, 93 (01) :123-132